Pharma Equity Group A/S: Financial statements 2020
CVR: 26791413
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -32,875,000 compared with DKK -14,417,000 the year before. Equity in the 2020 report amounted to DKK 34,281,000. The solvency ratio was 59.5%.
- Profit/Loss
- DKK -32,875,000
- Equity
- DKK 34,281,000
- Total Assets
- DKK 57,582,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | -32.9 mio. | 34.3 mio. | - |
| 2019 | - | - | -14.4 mio. | 67.2 mio. | - |
| 2018 | - | - | -7.7 mio. | 77.6 mio. | - |
| 2017 | - | - | -4.1 mio. | 103.3 mio. | - |
| 2016 | - | - | -2 mio. | 96.8 mio. | - |
Official annual report
How creditworthy is Pharma Equity Group A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 31, 2020, Jeanette Gyldstoff Borg has joined the board of directors of Pharma Equity Group A/S.
As of December 31, 2020, Peter Ole Jensen has joined the board of directors of Pharma Equity Group A/S.
As of December 31, 2020, Jeanette Gyldstoff Borg is registered as adm. dir. of Pharma Equity Group A/S.
As of December 31, 2020, Peter Miro Hauge Jensen has stepped down as adm. dir. of Pharma Equity Group A/S.
As of December 22, 2020, Rolf Gordon Adamson has left the board of directors of Pharma Equity Group A/S.
As of June 15, 2020, Ulrik Feldstedt Hjorth has left the board of directors of Pharma Equity Group A/S.
As of June 15, 2020, Nicolai Dines Kærgaard has left the board of directors of Pharma Equity Group A/S.
As of January 8, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Pharma Equity Group A/S.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.